Full Year Trading Update

In brief · summary, not quotable

Eco Animal Health Group plc announced a strong full-year trading update for the year ending 31 March 2026, with expected revenue growth of approximately 8% year-on-year, surpassing market expectations of £83.5 million and building on the prior year's £79.6 million. This growth, particularly in North and Latin America, coupled with improved gross margins driven by better pricing and cost of goods, is projected to result in a material increase in adjusted EBITDA over the previous year's £7.3 million, also exceeding market expectations of £7.6 million.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your EAH notes

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the following unaudited trading update for the year ending 31 March 2026.

As previously announced, trading in the first half of this financial year was significantly stronger compared to the same period last year. This trend has continued to year end with an expected year-on-year increase in revenue of c.8%, slightly ahead of market expectations1 (2025: £79.6 million). Revenue growth has been particularly strong in North America and Latin America, despite currency headwinds and tariff challenges.

The Company also expects to report improved gross margins for the year, primarily driven by improved product pricing and cost of goods. The combined effect of the stronger revenue and margins is expected to result in a material increase in adjusted EBITDA over the prior year (2025: £7.3m) with adjusted EBITDA also materially ahead of market expectations.1 The final outcome for the full year will be subject to the usual audit process, including the customary assessment of balance sheet provisioning.

The Company expects to report its audited full year results in early July.

1 The consensus market expectations for revenue and adjusted EBITDA for the year ending 31 March 2026 are £83.5m and £7.6m respectively.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.